Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
To be a shareholder in Brown & Brown, you’d want to believe in the company’s ability to maintain steady growth across its diversified insurance and risk management operations, even as it faces sector headwinds. The recent US$636.94 million ESOP-related equity shelf registration is unlikely to materially impact the main short-term catalyst, operational results from recent acquisitions, nor the biggest current risk, which remains exposure to softening CAT property rates. Among the company’s recent news, the Q2 2025 earnings announcement stands out. Revenue increased year-over-year, but net income and per-share earnings declined, signaling that while top-line growth continues, margin pressures and segment-specific risks are actively at play. However, investors should also be aware that, despite these positive signals, exposure to declining CAT property pricing could ...
Read the full narrative on Brown & Brown (it's free!)
Brown & Brown's outlook forecasts $9.1 billion in revenue and $1.7 billion in earnings by 2028. This is based on annual revenue growth of 22.0% and a $0.7 billion increase in earnings from the current $1.0 billion.
Uncover how Brown & Brown's forecasts yield a $117.55 fair value, a 27% upside to its current price.
Five Simply Wall St Community fair value estimates span US$71.17 to US$124.74 per share. Some see significance in the company’s revenue growth, but margin risks from CAT property exposure remain critical for performance.
Explore 5 other fair value estimates on Brown & Brown - why the stock might be worth 23% less than the current price!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Discover if Brown & Brown might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.